All In Biotech

Drug Trial Radar · NCT06359041

RESET-MG: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Generalized Myasthenia Gravis

RESET-MG: A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T Cells (CABA-201) in Participants With Generalized Myasthenia Gravis

Last checked: Nov 20, 2026Latest source record: Oct 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Dec 17, 2024

Primary completion

Sep 2029

Study completion Sep 2029

Sponsor

Lead sponsor
Cabaletta BioIndustry
Sponsor type
Industry
First posted
Apr 11, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

RESET-MG: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Participants with Generalized Myasthenia Gravis

Conditions

  • Generalized Myasthenia Gravis (gMG)

Interventions

  • CABA-201Biological

    Single intravenous infusion of CABA-201 at a single dose level following preconditioning with fludarabine and cyclophosphamide

  • CABA-201Biological

    Single intravenous infusion of CABA-201 at escalating dose levels without preconditioning

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. To evaluate incidence and severity of adverse events (AEs)Time frame: Up to 28 days after CABA-201 infusion

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • University of California Irvine

    Orange, California · Recruiting

  • UC Davis, Department of Neurology

    Sacramento, California · Recruiting

  • University of California, San Francisco

    San Francisco, California · Recruiting

  • University of Colorado

    Aurora, Colorado · Recruiting

  • Mayo Clinic Florida

    Jacksonville, Florida · Recruiting

  • Northwestern Memorial Hospital

    Chicago, Illinois · Recruiting

  • University of Kansas Medical Center

    Kansas City, Kansas · Recruiting

  • Beth Israel Deaconess Medical Center

    Boston, Massachusetts · Recruiting

  • University of Massachusetts Chan Medical School

    Worcester, Massachusetts · Recruiting

  • Mayo Clinic - Rochester

    Rochester, Minnesota · Recruiting

  • Columbia University

    New York, New York · Recruiting

  • University of Rochester Medical Center

    Rochester, New York · Recruiting

  • Oregon Health & Science University

    Portland, Oregon · Recruiting

  • Baylor College of Medicine Neurology Department

    Houston, Texas · Recruiting

  • Houston Methodist Hospital

    Houston, Texas · Recruiting

  • University of Texas MD Anderson Cancer Center

    Houston, Texas · Recruiting

  • Swedish Neuroscience Research

    Seattle, Washington · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.